MERCK SHARP DOHME FDA Approval NDA 209764

NDA 209764

MERCK SHARP DOHME

FDA Drug Application

Application #209764

Documents

Letter2018-02-26

Application Sponsors

NDA 209764MERCK SHARP DOHME

Marketing Status

None (Tentative Approval)001

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1TA2018-02-22STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

MERCK SHARP DOHME
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209764
            [companyName] => MERCK SHARP DOHME
            [docInserts] => ["",""]
            [products] => [{"drugName":"LUSDUNA","activeIngredients":"INSULIN GLARGINE","strength":"100UNITS\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/22\/2018","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/209764Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-02-22
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.